What are the anesthetic implications for pheochromocytoma removal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthetic Implications for Pheochromocytoma Removal

The most critical anesthetic implication for pheochromocytoma removal is mandatory preoperative alpha-adrenergic blockade for 10-14 days before surgery to prevent potentially life-threatening hypertensive crises and arrhythmias during tumor manipulation. 1, 2

Preoperative Management

Alpha-Adrenergic Blockade

  • Preoperative alpha-adrenergic blockade must be initiated at least 7-14 days before surgery with gradually increasing dosages 1, 2
  • Blood pressure targets: <130/80 mmHg supine and systolic blood pressure >90 mmHg in upright position 1, 2
  • Two main options for alpha blockade:
    • Non-selective, non-competitive alpha-blocker: Phenoxybenzamine (starting dose 10 mg twice daily with adjustments every 2-4 days) 1, 3
    • Selective alpha-1 blockers: Doxazosin, prazosin, or terazosin 1
  • The PRESCRIPT trial showed phenoxybenzamine may provide less intraoperative hemodynamic instability compared to doxazosin, though both are effective 1, 4

Beta-Adrenergic Blockade

  • Beta-blockers should ONLY be added AFTER adequate alpha blockade to control tachyarrhythmias 1, 2
  • Never use beta-blockers alone as monotherapy, as this can precipitate hypertensive crisis due to unopposed alpha-adrenergic stimulation 5
  • Preferably use cardioselective beta-1 blockers when needed 1

Additional Preoperative Measures

  • High-sodium diet and administration of 1-2 liters of saline 24 hours prior to surgery 1, 2
  • Use of compressive stockings to reduce risk of orthostatic and postoperative hypotension 1, 2
  • Calcium channel blockers may be used as adjuncts to alpha-blockers for refractory hypertension 1, 2
  • Metyrosine (alpha-methyl-p-tyrosine), a catecholamine synthesis inhibitor, can be used as an add-on medication where available to further reduce catecholamine production 1, 6

Intraoperative Management

Hemodynamic Management

  • Hypertension during surgery may be treated with:
    • Magnesium sulfate
    • Intravenous alpha-adrenergic antagonist (phentolamine)
    • Calcium channel blockers
    • Nitroprusside
    • Nitroglycerin 1, 2
  • Tachycardia can be treated with intravenous beta-blockers such as esmolol 2, 5
  • Patients who receive adequate preoperative alpha blockade (particularly higher doses of phenoxybenzamine) require significantly less intraoperative vasodilators 7

Critical Phases

  • Most significant hemodynamic instability occurs during:
    • Induction of anesthesia
    • Tumor manipulation
    • Immediately after tumor removal (risk of hypotension) 2
  • Careful monitoring of blood pressure and heart rate is essential throughout the procedure 2

Surgical Approach Considerations

  • Laparoscopic adrenalectomy is preferred for most pheochromocytomas, showing better intraoperative hemodynamic stability compared to open surgery 2
  • Open surgery should be considered for tumors with high suspicion of malignancy, large size (>6 cm), or local invasion 2

Postoperative Management

Immediate Postoperative Care

  • Aggressive treatment of postoperative hypotension is essential due to sudden decrease in catecholamine levels 8
  • Close monitoring of blood glucose levels is crucial as hypoglycemia commonly occurs after reduction of catecholamine levels 8
  • For bilateral adrenalectomy, high-dose hydrocortisone (150 mg/day) should be administered during the immediate postoperative period 8

Monitoring

  • Postoperative biochemical testing should be performed 2-8 weeks after surgery to confirm complete resection 1, 8
  • Imaging should be done at 3-6 months postoperatively 1, 8

Special Considerations and Pitfalls

Potential Complications

  • Inadequate preoperative alpha blockade can lead to severe hypertensive crises during tumor manipulation 1, 6
  • Excessive alpha blockade can cause significant postoperative hypotension requiring vasopressors 4
  • Premature beta blockade (before adequate alpha blockade) can precipitate hypertensive crisis 5
  • Patients with exclusively dopamine-producing pheochromocytomas (indicated by isolated elevation of plasma methoxytyramine) do not require preoperative alpha blockade 1

Comprehensive Evaluation

  • All patients with adrenal masses should undergo comprehensive hormonal evaluation, including testing for both catecholamine excess and other hormone abnormalities 9
  • Never perform adrenal biopsy without excluding pheochromocytoma first, as this can trigger life-threatening hypertensive crisis 9

By following these guidelines for preoperative preparation and intraoperative management, the anesthetic risks associated with pheochromocytoma removal can be significantly minimized, improving patient outcomes and reducing perioperative morbidity and mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Operative Management of Bilateral Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metyrosine and pheochromocytoma.

Archives of internal medicine, 1997

Guideline

Postoperative Management of Bilateral Adrenalectomy for Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pheochromocytoma and Aldosterone Excess

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.